Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Eno Pharm is a specialized pharmaceutical technology company based in Wuhan, China, focusing on the research, development, and manufacturing of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company provides comprehensive services including custom synthesis, process development, and contract manufacturing (CMO/CDMO) to global pharmaceutical and biotech firms. Their product portfolio primarily supports therapeutic areas such as oncology, antiviral, and cardiovascular diseases through the supply of complex small molecule building blocks. Operating out of the Wuhan East Lake High-tech Development Zone, the company leverages advanced chemical synthesis technologies to provide cost-effective solutions for drug discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Eno Pharm.